PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19
- PMID: 32978778
- PMCID: PMC7537078
- DOI: 10.1002/cpt.2067
PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19
Abstract
Pharmacogenomics (PGx) is a key area of precision medicine, which is already being implemented in some health systems and may help guide clinicians toward effective therapies for individual patients. Over the last 2 decades, the Pharmacogenomics Knowledgebase (PharmGKB) has built a unique repository of PGx knowledge, including annotations of clinical guideline and regulator-approved drug labels in addition to evidence-based drug pathways and annotations of the scientific literature. All of this knowledge is freely accessible on the PharmGKB website. In the first of a series of PharmGKB tutorials, we introduce the PharmGKB coronavirus disease 2019 (COVID-19) portal and, using examples of drugs found in the portal, demonstrate some of the main features of PharmGKB. This paper is intended as a resource to help users become quickly acquainted with the wealth of information stored in PharmGKB.
© 2020 The Authors. Clinical Pharmacology & Therapeutics © 2020 American Society for Clinical Pharmacology and Therapeutics.
Conflict of interest statement
R.B.A. is a stockholder in Personalis, 23andMe, and Youscript. All other authors declared no competing interests for this work.
Figures






Similar articles
-
PharmGKB: A worldwide resource for pharmacogenomic information.Wiley Interdiscip Rev Syst Biol Med. 2018 Jul;10(4):e1417. doi: 10.1002/wsbm.1417. Epub 2018 Feb 23. Wiley Interdiscip Rev Syst Biol Med. 2018. PMID: 29474005 Free PMC article. Review.
-
PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge.Curr Protoc. 2021 Aug;1(8):e226. doi: 10.1002/cpz1.226. Curr Protoc. 2021. PMID: 34387941 Free PMC article.
-
Pharmacogenomics knowledge for personalized medicine.Clin Pharmacol Ther. 2012 Oct;92(4):414-7. doi: 10.1038/clpt.2012.96. Clin Pharmacol Ther. 2012. PMID: 22992668 Free PMC article. Review.
-
Contemporary pharmacogenetic assays in view of the PharmGKB database.Pharmacogenomics. 2019 Mar;20(4):261-272. doi: 10.2217/pgs-2018-0167. Epub 2019 Mar 18. Pharmacogenomics. 2019. PMID: 30883266
-
PGxMine: Text mining for curation of PharmGKB.Pac Symp Biocomput. 2020;25:611-622. Pac Symp Biocomput. 2020. PMID: 31797632 Free PMC article.
Cited by
-
Impact of FCGR2A rs1801274 and IL-6R rs2228145 polymorphisms on tocilizumab response in the Iranian population with severe COVID-19.BMC Infect Dis. 2024 Oct 16;24(1):1168. doi: 10.1186/s12879-024-10073-0. BMC Infect Dis. 2024. PMID: 39415081 Free PMC article.
-
Advancing Precision Medicine Through the New Pharmacogenomics Global Research Network.Clin Pharmacol Ther. 2021 Sep;110(3):559-562. doi: 10.1002/cpt.2340. Epub 2021 Jul 28. Clin Pharmacol Ther. 2021. PMID: 34318925 Free PMC article.
-
The Role of NCS1 in Immunotherapy and Prognosis of Human Cancer.Biomedicines. 2023 Oct 12;11(10):2765. doi: 10.3390/biomedicines11102765. Biomedicines. 2023. PMID: 37893139 Free PMC article.
-
INTEDE 2.0: the metabolic roadmap of drugs.Nucleic Acids Res. 2024 Jan 5;52(D1):D1355-D1364. doi: 10.1093/nar/gkad1013. Nucleic Acids Res. 2024. PMID: 37930837 Free PMC article.
-
Active Constituent of HQS in T2DM Intervention: Efficacy and Mechanistic Insights.Int J Mol Sci. 2025 May 10;26(10):4578. doi: 10.3390/ijms26104578. Int J Mol Sci. 2025. PMID: 40429723 Free PMC article.
References
-
- PharmGKB . Drug label information and legend <https://www.pharmgkb.org/page/drugLabelLegend> (2020). Accessed August 10, 2020.
-
- PharmGKB . Clinical annotation levels of evidence <https://www.pharmgkb.org/page/clinAnnLevels> (2020). Accessed August 10, 2020.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical